Brain Cancer
Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
Published in Health Business Week, June 12th, 2009
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and serious virus infections, today provided an update on progress in the company's clinical program for Cotara(R), a targeted monoclonal antibody-based therapy being tested in a Phase II trial as a potential new treatment for recurrent glioblastoma multiforme (GBM), a deadly form of brain cancer. The company also reported that patient enrollment in the final cohort of a second Cotara GBM trial, a dose confirmation and dosimetry study, is nearing completion and that interim data from this trial has been accepted for an oral presentation at...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2009-06-12)
More Articles from Health Business Week
- 4SC AG
4SC presents Phase I data on its histone deacetylase HDAC inhibitor 4SC-201 at ASCO - A. Schulman, Inc.
A. Schulman Appoints Kim L. Whiteman to Head Global Human Resources Team - A. Schulman, Inc.
A. Schulman Expands Sunprene Elastomers Line for Industrial, Specialty Wire & Cable, and Heavy Truck Markets - ABI Research
Wireless Communications Sector Will Reap Huge Benefit from $6.8 Billion Stimulus Bill Funding, Says ABI Research - Abraxis BioScience, Inc.
Marty J. Duvall Joins Abraxis BioScience as Senior Vice President, Global Marketing and International Commercial Operations - Acacia Research Corporation
Acacia Subsidiary Enters into License Agreement with KYRSAGIH BROS. LIMITED LIABILITY COMPANY - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
